Kura Oncology, Inc. (KURA)
9.40
-0.16
(-1.67%)
USD |
NASDAQ |
May 07, 10:53
Kura Oncology Cash from Investing (Quarterly) : -64.60M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -20.32B |
| ANI Pharmaceuticals, Inc. | -1.403M |
| Lexicon Pharmaceuticals, Inc. | 4.83M |
| Novavax, Inc. | -28.36M |
| Liquidia Corp. | -4.038M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 117.27M |
| Cash from Financing (Quarterly) | 1.135M |
| Free Cash Flow | -70.70M |
| Free Cash Flow Per Share (Quarterly) | 1.306 |
| Free Cash Flow to Equity (Quarterly) | 113.96M |
| Free Cash Flow to Firm (Quarterly) | 115.30M |
| Free Cash Flow Yield | -8.58% |